Skip to content
Optionomics Free · No account needed

Options flow · Regencell Bioscience Holdings Limited Ordinary

RGC options flow

Last full session · September 23, 2026 · Delayed and summarised

Where the premium went

Call premium minus put premium, session by session.

15 sessions
May 28: $16.0K more on calls Jun 11: $10.4K more on calls Jun 16: $28.2K more on puts Jun 18: $49.0K more on puts Jun 24: $7.2K more on puts Jul 1: $117.9K more on calls Jul 8: $10.9K more on puts Jul 13: $0 more on calls Jul 14: $0 more on calls Jul 15: $0 more on calls Jul 16: $0 more on calls Jul 17: $76.6K more on calls Jul 24: $0 more on calls Aug 7: $40 more on calls Sep 23: $10.3K more on calls More on calls More on puts Largest net: $117.9K May 28 Sep 23

Above zero: more spent on calls. Below zero: more on puts. Bar heights share a scale within this stock's history; premium alone does not tell us whether a trade was bought or sold.

Put the activity in context

Derived readings from the same completed session.

Relative options cost

14%
14%

Options are unusually cheap — higher than 14% of the last year for this stock

Most is riding on $2.50 and $7.50
the prices with the most contracts still open above and below
Trading far below its 52-week high
+8.7% over the last month
How to read these figures

Every reading here is one we computed from that session. The history plots the difference between aggregate call and put premium, scaled to the largest absolute reading in this window.

Institutional-looking activity is inferred from trade size and shape. Sweeps span multiple venues. Neither tells us who traded or guarantees a directional move.

Relative options cost compares this stock with its own past year. It is not the stock's implied volatility quoted as a percentage.